Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Matoba

Showing results (61-70 of 166) with videos related to

Pageof 17
Sort By:
Cardiovascular Research|January 16, 2026
Drp1-mediated mitochondrial fission protects macrophages from mtDNA/ZBP1-mediated inflammation and inhibits post-infarct cardiac remodelingYuki Kondo, Jun-Ichiro Koga, Nasanbadrakh Orkhonselenge, et al.
Journal of Atherosclerosis and Thrombosis|October 15, 2011
Imatinib mesylate-incorporated nanoparticle-eluting stent attenuates in-stent neointimal formation in porcine coronary arteriesSeigo Masuda, Kaku Nakano, Kouta Funakoshi, et al.
Plos One|July 14, 2015
A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat ModelKazuhiro Nagaoka, Tetsuya Matoba, Yajing Mao, et al.
Hypertension (Dallas, Tex. : 1979)|January 12, 2011
Nanoparticle-mediated delivery of pitavastatin into lungs ameliorates the development and induces regression of monocrotaline-induced pulmonary artery hypertensionLing Chen, Kaku Nakano, Satoshi Kimura, et al.
Journal of Atherosclerosis and Thrombosis|September 19, 2012
Pitavastatin-incorporated nanoparticle-eluting stents attenuate in-stent stenosis without delayed endothelial healing effects in a porcine coronary artery modelNoriaki Tsukie, Kaku Nakano, Tetsuya Matoba, et al.
Scientific Reports|September 1, 2022
Dietary 7-ketocholesterol exacerbates myocardial ischemia-reperfusion injury in mice through monocyte/macrophage-mediated inflammationTomoki Uchikawa, Tetsuya Matoba, Takuro Kawahara, et al.
International Heart Journal|August 31, 2018
Safety, Tolerability, and Pharmacokinetics of NK-104-NPKaku Nakano, Tetsuya Matoba, Jun-Ichiro Koga, et al.
The Journal of Clinical Investigation|December 18, 2003
Pivotal role of Cu,Zn-superoxide dismutase in endothelium-dependent hyperpolarizationKeiko Morikawa, Hiroaki Shimokawa, Tetsuya Matoba, et al.
JACC. Cardiovascular Interventions|November 5, 2021
Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting: Insights From the AFIRE TrialTetsuya Matoba, Satoshi Yasuda, Koichi Kaikita, et al.
JAMA Cardiology|August 13, 2025
Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Post Hoc Analysis of the AFIRE Randomized Clinical TrialJunichi Yamaguchi, Hiroyuki Arashi, Nobuhisa Hagiwara, et al.
Pageof 17

Showing results (61-70 of 166) with videos related to

Sort By:
Pageof 17
Cardiovascular Research|January 16, 2026
Drp1-mediated mitochondrial fission protects macrophages from mtDNA/ZBP1-mediated inflammation and inhibits post-infarct cardiac remodelingYuki Kondo, Jun-Ichiro Koga, Nasanbadrakh Orkhonselenge, et al.
Journal of Atherosclerosis and Thrombosis|October 15, 2011
Imatinib mesylate-incorporated nanoparticle-eluting stent attenuates in-stent neointimal formation in porcine coronary arteriesSeigo Masuda, Kaku Nakano, Kouta Funakoshi, et al.
Plos One|July 14, 2015
A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat ModelKazuhiro Nagaoka, Tetsuya Matoba, Yajing Mao, et al.
Hypertension (Dallas, Tex. : 1979)|January 12, 2011
Nanoparticle-mediated delivery of pitavastatin into lungs ameliorates the development and induces regression of monocrotaline-induced pulmonary artery hypertensionLing Chen, Kaku Nakano, Satoshi Kimura, et al.
Journal of Atherosclerosis and Thrombosis|September 19, 2012
Pitavastatin-incorporated nanoparticle-eluting stents attenuate in-stent stenosis without delayed endothelial healing effects in a porcine coronary artery modelNoriaki Tsukie, Kaku Nakano, Tetsuya Matoba, et al.
Scientific Reports|September 1, 2022
Dietary 7-ketocholesterol exacerbates myocardial ischemia-reperfusion injury in mice through monocyte/macrophage-mediated inflammationTomoki Uchikawa, Tetsuya Matoba, Takuro Kawahara, et al.
International Heart Journal|August 31, 2018
Safety, Tolerability, and Pharmacokinetics of NK-104-NPKaku Nakano, Tetsuya Matoba, Jun-Ichiro Koga, et al.
The Journal of Clinical Investigation|December 18, 2003
Pivotal role of Cu,Zn-superoxide dismutase in endothelium-dependent hyperpolarizationKeiko Morikawa, Hiroaki Shimokawa, Tetsuya Matoba, et al.
JACC. Cardiovascular Interventions|November 5, 2021
Rivaroxaban Monotherapy in Patients With Atrial Fibrillation After Coronary Stenting: Insights From the AFIRE TrialTetsuya Matoba, Satoshi Yasuda, Koichi Kaikita, et al.
JAMA Cardiology|August 13, 2025
Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Post Hoc Analysis of the AFIRE Randomized Clinical TrialJunichi Yamaguchi, Hiroyuki Arashi, Nobuhisa Hagiwara, et al.
Pageof 17